276 related articles for article (PubMed ID: 9595401)
1. Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1.
Takayanagi R; Liu W; Ito T; Ohnaka K; Nawata H
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S62-3. PubMed ID: 9595401
[TBL] [Abstract][Full Text] [Related]
2. [Phe21]big endothelin-1(18-34) and [Ala31]big endothelin-1(18-34) inhibit the human endothelin-converting enzyme-1 (ECE-1) expressed in CHO-K1 cells in a different fashion.
Liu W; Takayanagi R; Ito T; Oba K; Nawata H
FEBS Lett; 1997 Dec; 420(1):103-6. PubMed ID: 9450558
[TBL] [Abstract][Full Text] [Related]
3. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
Yap EY; Battistini B; McKay KO
Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.
Emoto N; Yanagisawa M
J Biol Chem; 1995 Jun; 270(25):15262-8. PubMed ID: 7797512
[TBL] [Abstract][Full Text] [Related]
5. Molecular pharmacology of endothelin converting enzymes.
Turner AJ; Murphy LJ
Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
[TBL] [Abstract][Full Text] [Related]
6. D-Val22 containing human big endothelin-1 analog, [D-Val22]Big ET-1[16-38], inhibits the endothelin converting enzyme.
Morita A; Nomizu M; Okitsu M; Horie K; Yokogoshi H; Roller PP
FEBS Lett; 1994 Oct; 353(1):84-8. PubMed ID: 7926029
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CGS 31447, a potent and nonpeptidic endothelin-converting enzyme inhibitor.
Shetty SS; Savage P; DelGrande D; De Lombaert S; Jeng AY
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S68-70. PubMed ID: 9595403
[TBL] [Abstract][Full Text] [Related]
8. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1.
Xu D; Emoto N; Giaid A; Slaughter C; Kaw S; deWit D; Yanagisawa M
Cell; 1994 Aug; 78(3):473-85. PubMed ID: 8062389
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-2-converting enzyme from human renal adenocarcinoma cells is a phosphoramidon-sensitive, membrane-bound metalloprotease.
Shinmi O; Yorimitsu K; Moroi K; Nishiyama M; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S61-4. PubMed ID: 7510000
[TBL] [Abstract][Full Text] [Related]
10. Novel selective quinazoline inhibitors of endothelin converting enzyme-1.
Ahn K; Sisneros AM; Herman SB; Pan SM; Hupe D; Lee C; Nikam S; Cheng XM; Doherty AM; Schroeder RL; Haleen SJ; Kaw S; Emoto N; Yanagisawa M
Biochem Biophys Res Commun; 1998 Feb; 243(1):184-90. PubMed ID: 9473502
[TBL] [Abstract][Full Text] [Related]
11. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme.
Claing A; Neugebauer W; Yano M; Rae GA; D'Orléans-Juste P
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S72-4. PubMed ID: 8587472
[TBL] [Abstract][Full Text] [Related]
12. In vivo role of endothelin-converting enzyme-1 as examined by adenovirus-mediated overexpression in rats.
Télémaque S; Emoto N; deWit D; Yanagisawa M
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S548-50. PubMed ID: 9595539
[TBL] [Abstract][Full Text] [Related]
13. The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1.
Raoch V; Martinez-Miguel P; Arribas-Gomez I; Rodriguez-Puyol M; Rodriguez-Puyol D; Lopez-Ongil S
Br J Pharmacol; 2007 Oct; 152(3):313-22. PubMed ID: 17643133
[TBL] [Abstract][Full Text] [Related]
14. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
[TBL] [Abstract][Full Text] [Related]
15. Purification of a novel endothelin-converting enzyme specific for big endothelin-3.
Hasegawa H; Hiki K; Sawamura T; Aoyama T; Okamoto Y; Miwa S; Shimohama S; Kimura J; Masaki T
FEBS Lett; 1998 May; 428(3):304-8. PubMed ID: 9654154
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells.
Azarani A; Boileau G; Crine P
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):439-48. PubMed ID: 9657986
[TBL] [Abstract][Full Text] [Related]
17. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations.
Schweizer A; Valdenaire O; Nelböck P; Deuschle U; Dumas Milne Edwards JB; Stumpf JG; Löffler BM
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):871-7. PubMed ID: 9396733
[TBL] [Abstract][Full Text] [Related]
18. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
[TBL] [Abstract][Full Text] [Related]
19. Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities.
Rizzi A; Calo G; Battistini B; Regoli D
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S58-61. PubMed ID: 9595400
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelin-converting enzyme, chymase and neutral endopeptidase in the processing of big ET-1, ET-1(1-21) and ET-1(1-31) in the trachea of allergic mice.
De Campo BA; Goldie RG; Jeng AY; Henry PJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():353S-356S. PubMed ID: 12193121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
